| Interpretive Data: |
Background Information for Ornithine Transcarbamylase Deficiency (OTC) Sequencing:
Characteristics: Classic OTC deficiency is a urea cycle disorder characterized by hyperammonemia, cyclical vomiting, seizures, lethargy, coma and neonatal death if not treated. Clinical presentation varies widely in females, and some males can have non-classical forms.
Incidence: Approximately 1 in 20,000.
Inheritance: X-linked.
Penetrance: Variable depending on sex and mutation.
Cause: Pathogenic OTC gene mutations.
Clinical Sensitivity: Approximately 80 percent.
Methodology: Bidirectional sequencing of the entire OTC coding region and intron/exon boundaries.
Analytical Sensitivity and Specificity: 99 percent.
Limitations: Rare diagnostic errors can occur due to primer site mutations. Regulatory region mutations and deep intronic mutations will not be detected in individuals of both sexes; large deletions/duplications will not be detected in females.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
Refer to Statement C under Testing Information at http://www.aruplab.com.
|
| CPT Code(s): |
83891 Isolation; 83898 x10 Amplification; 83904 x10 Sequencing; 83909 Capillary electrophoresis; 83912 Interpretation and report - Additional CPT code modifiers may be required for procedures performed to test for oncologic or inherited disorders.
|
Cross References: |
OTC Sequencing (Ornithine Transcarbamylase Deficiency (OTC) Sequencing)
, Urea Cycle Defect (Ornithine Transcarbamylase Deficiency (OTC) Sequencing)
|
![[ image for: Patient History for Ornithine Transcarbamylase Deficiency (OTC) Testing]](icon_78.jpg){kind=icon}